• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Biochem Biophys Res Commun . ACE2 contributes to the maintenance of mouse epithelial barrier function

tetano

Editor, Senior Moderator
Biochem Biophys Res Commun


. 2020 Oct 20;S0006-291X(20)31906-9.
doi: 10.1016/j.bbrc.2020.10.002. Online ahead of print.
ACE2 contributes to the maintenance of mouse epithelial barrier function


Wei Yu[SUP] 1 [/SUP], Xianhong Ou[SUP] 2 [/SUP], Xiaofan Liu[SUP] 1 [/SUP], Shuaixu Zhang[SUP] 1 [/SUP], Xinxin Gao[SUP] 1 [/SUP], Hongju Cheng[SUP] 1 [/SUP], Baoliang Zhu[SUP] 1 [/SUP], Jing Yan[SUP] 3 [/SUP]



Affiliations

Abstract

Background: The whole world was hit hard by the coronavirus disease-19 (COVID-19). Given that angiotensin I converting enzyme 2 (ACE2) is the viral entry molecule, understanding ACE2 has become a major focus of current COVID-19 research. ACE2 is highly expressed in the gut, but its role has not been fully understood and thus COVID-19 treatments intending to downregulate ACE2 level may cause untoward side effects. Gaining insight into the functions of ACE2 in gut homeostasis therefore merits closer examination, and is beneficial to find potential therapeutic alternatives for COVID-19.
Methods: We took advantage of Ace2 knockout out mice and isolated intestinal organoids to examine the role of ACE2 in intestinal stemness. Inflammatory bowel disease (IBD) mouse model was established by 4% dextran sodium sulfate. LGR5 and KI67 levels were quantitated to reflect the virtue of intestinal stem cells (ISCs). FITC-dextran 4 (FD-4) assay was used to assess intestinal barrier function.
Results: Western blotting identified the expression of ACE2 in colon, which was consistent with the results of immunofluorescence and RT-PCR. Moreover, Ace2[SUP]-/-[/SUP] organoids showed decreased LRG5 and KI67 levels, and elevated calcium concentration. Furthermore, the permeability of ace2[SUP]-/-[/SUP] organoids was markedly increased compared with ace2[SUP]+/+[/SUP] organoids. Collectively, ace2[SUP]-/-[/SUP] mice were more susceptible than ace2[SUP]+/+[/SUP] mice to IBD, including earlier bloody stool, undermined intestinal architecture and more pronounced weight loss.
Conclusions: Our data reveal that ACE2 contributes to the proliferation of intestinal stem cells and hence orchestrates the mucosal homeostasis.

Keywords: ACE2; Inflammatory bowel disease; Mucosal homeostasis; Organoids.
 
Back
Top Bottom